CN Patent

CN106892929B — 螺缩酮衍生物及其制备方法和应用

Assigned to Shanghai Allist Medicine Polytron Technologies Inc · Expires 2020-01-14 · 6y expired

What this patent protects

本发明涉及下式(I)螺缩酮衍生物及其制备方法和应用，式中R 1 、R 2 、R 3 、R 4 、X以及A环的定义请见说明书。本发明衍生物是与肠或肾脏的葡萄糖再吸收有关的钠依赖性葡萄糖协同转运蛋白2(SGLT‑2)抑制剂，具有良好的尿糖排泄作用，从而可用作治疗糖尿病、高血糖症、及由它们引起的糖尿病并发症或肥胖症的治疗剂。

USPTO Abstract

本发明涉及下式(I)螺缩酮衍生物及其制备方法和应用，式中R 1 、R 2 、R 3 、R 4 、X以及A环的定义请见说明书。本发明衍生物是与肠或肾脏的葡萄糖再吸收有关的钠依赖性葡萄糖协同转运蛋白2(SGLT‑2)抑制剂，具有良好的尿糖排泄作用，从而可用作治疗糖尿病、高血糖症、及由它们引起的糖尿病并发症或肥胖症的治疗剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN106892929B
Jurisdiction
CN
Classification
—
Expires
2020-01-14
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Allist Medicine Polytron Technologies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.